pirenzepine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passik, SD | 1 |
| Cooper, M | 1 |
1 other study available for pirenzepine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Complicated delirium in a cancer patient successfully treated with olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Lymphoma, Non-Hodgkin; Middle Ag | 1999 |